These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Genetic factors and the founder effect explain familial MS in Sardinia. Marrosu MG; Lai M; Cocco E; Loi V; Spinicci G; Pischedda MP; Massole S; Marrosu G; Contu P Neurology; 2002 Jan; 58(2):283-8. PubMed ID: 11805258 [TBL] [Abstract][Full Text] [Related]
28. Anticipation of age at onset in familial multiple sclerosis. Romero-Pinel L; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Kremenchutzky M; Arbizu T Eur J Neurol; 2010 Apr; 17(4):572-5. PubMed ID: 20002735 [TBL] [Abstract][Full Text] [Related]
29. No excess of autoimmune diseases in multiple sclerosis families from the Netherlands. Mescheriakova JY; Hintzen RQ Acta Neurol Scand; 2018 May; 137(5):531-537. PubMed ID: 29315461 [TBL] [Abstract][Full Text] [Related]
30. The influence of gender on the susceptibility to multiple sclerosis in sibships. Sadovnick AD; Bulman DE; Hashimoto L; D'Hooghe MB; Ebers GC Arch Neurol; 1991 Jun; 48(6):586-8. PubMed ID: 2039379 [TBL] [Abstract][Full Text] [Related]
31. MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases. Moghadam NB; Ghaffari M; Rashed SS; Valaie N; Hesami O; Niloofar P; Ghazanfari Y Mult Scler Relat Disord; 2021 Nov; 56():103235. PubMed ID: 34678703 [TBL] [Abstract][Full Text] [Related]
32. Autoimmune disease in families with multiple sclerosis: a population-based study. Ramagopalan SV; Dyment DA; Valdar W; Herrera BM; Criscuoli M; Yee IM; Sadovnick AD; Ebers GC; Lancet Neurol; 2007 Jul; 6(7):604-10. PubMed ID: 17560172 [TBL] [Abstract][Full Text] [Related]
33. [Sporadic and familial-occurring multiple sclerosis. HLA typing and study of chromosomal sister chromatid exchange rate]. Träder JM; Warecka K; Schwinger E Fortschr Neurol Psychiatr; 1985 Apr; 53(4):134-7. PubMed ID: 3997038 [TBL] [Abstract][Full Text] [Related]
34. [The use of magnetic resonance imaging in the study of asymptomatic familial multiple sclerosis patients]. Barakat Shrem O; Fernández Pérez MJ; Benavente Fernández A; García Moreno JM; Ruiz Peña JL; Fajardo Galvez J; Izquierdo G Rev Neurol; 2003 Nov 1-15; 37(9):811-4. PubMed ID: 14606046 [TBL] [Abstract][Full Text] [Related]
35. Similar familial risk in multiple sclerosis subgroups. Song J; Karrenbauer V; Manouchehrinia A; Almqvist C; Hillert J; Westerlind H Mult Scler; 2017 Nov; 23(13):1782-1785. PubMed ID: 28090800 [TBL] [Abstract][Full Text] [Related]
36. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
37. [Familial multiple sclerosis: a study of six families]. Landete L; Casanova B; Burguera JA Rev Neurol; 1998 Jul; 27(155):43-7. PubMed ID: 9674023 [TBL] [Abstract][Full Text] [Related]
38. European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. Sadovnick AD J Neurol Sci; 2009 Nov; 286(1-2):1-5. PubMed ID: 19782378 [TBL] [Abstract][Full Text] [Related]
39. Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis. Siger-Zajdel M; Selmaj K J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):752-6. PubMed ID: 11723195 [TBL] [Abstract][Full Text] [Related]
40. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015. Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]